Fluetonitazene (fluornitrazene, F-etonitazene, 2-fluoroetonitazene) is a benzimidazole derivative which is an opioid designer drug. It was patented in 2024 as a potential novel analgesic, but appeared on the illicit market at around the same time, first being identified in Germany in March 2024.
Fluetonitazene (fluornitrazene, F-etonitazene, 2-fluoroetonitazene) is a benzimidazole derivative which is an opioid designer drug. It was patented in 2024 as a potential novel analgesic, but appeared on the illicit market at around the same time, first being identified in Germany in March 2024.
Source: Wikipedia "Fluetonitazene" · CC BY-SA 4.0
Share this article: X · Bluesky